NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

The PR only states “after certain legal condition are fulfilled” which I assume has to do with the UK government and a U.S. company? It says nothing about waiting for MHRA approval.

>>The consideration for the acquisition will be paid in installments over two years, beginning 90 days after the acquisition agreement, with potential acceleration after regulatory approval of the Company’s DCVax®-L product. The consideration will include a payment of £1.4 million, and payment of the net amount of accounts payable (“Net AP”) due from the Company to Advent as of the date of the acquisition agreement for services already performed by Advent under the existing service contracts and Statements of Work (SOWs) that have been reported in the Company’s public filings. The Net AP payable by the Company will be the outstanding accounts payable on the agreement date reduced by certain adjustments between the parties.